Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
DBX2
|
ENSG00000185610.6 | developing brain homeobox 2 |
HLX
|
ENSG00000136630.11 | H2.0 like homeobox |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HLX | hg19_v2_chr1_+_221054411_221054411 | -0.65 | 5.6e-05 | Click! |
DBX2 | hg19_v2_chr12_-_45444873_45444888 | 0.24 | 1.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_13517565 | 3.28 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr10_+_69865866 | 3.25 |
ENST00000354393.2
|
MYPN
|
myopalladin |
chr12_-_10978957 | 2.73 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
chr9_-_28670283 | 2.40 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
chr11_-_26593649 | 2.04 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
chrX_-_73072534 | 1.97 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr7_+_123241908 | 1.95 |
ENST00000434204.1
ENST00000437535.1 ENST00000451215.1 |
ASB15
|
ankyrin repeat and SOCS box containing 15 |
chr11_-_26593779 | 1.94 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
chr2_+_182850551 | 1.89 |
ENST00000452904.1
ENST00000409137.3 ENST00000280295.3 |
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
chr6_-_25874440 | 1.82 |
ENST00000361703.6
ENST00000397060.4 |
SLC17A3
|
solute carrier family 17 (organic anion transporter), member 3 |
chr3_-_194072019 | 1.69 |
ENST00000429275.1
ENST00000323830.3 |
CPN2
|
carboxypeptidase N, polypeptide 2 |
chr11_-_26593677 | 1.59 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
chr2_+_135596106 | 1.58 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chrX_-_73061339 | 1.52 |
ENST00000602863.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr3_-_20053741 | 1.47 |
ENST00000389050.4
|
PP2D1
|
protein phosphatase 2C-like domain containing 1 |
chrX_-_15332665 | 1.43 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr10_-_27529486 | 1.40 |
ENST00000375888.1
|
ACBD5
|
acyl-CoA binding domain containing 5 |
chr16_+_15489629 | 1.36 |
ENST00000396385.3
|
MPV17L
|
MPV17 mitochondrial membrane protein-like |
chr18_-_48346415 | 1.35 |
ENST00000431965.2
ENST00000436348.2 |
MRO
|
maestro |
chr2_+_135596180 | 1.27 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr17_+_68071389 | 1.27 |
ENST00000283936.1
ENST00000392671.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr9_+_12693336 | 1.25 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
chr12_+_101988627 | 1.25 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr18_-_48346298 | 1.24 |
ENST00000398439.3
|
MRO
|
maestro |
chr10_+_32873190 | 1.24 |
ENST00000375025.4
|
C10orf68
|
Homo sapiens coiled-coil domain containing 7 (CCDC7), transcript variant 5, mRNA. |
chr7_+_138915102 | 1.20 |
ENST00000486663.1
|
UBN2
|
ubinuclein 2 |
chr1_+_202385953 | 1.18 |
ENST00000466968.1
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr11_-_128894053 | 1.17 |
ENST00000392657.3
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr12_+_101988774 | 1.16 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr8_+_134125727 | 1.15 |
ENST00000521107.1
|
TG
|
thyroglobulin |
chr5_-_125930929 | 1.13 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
chr1_+_117963209 | 1.11 |
ENST00000449370.2
|
MAN1A2
|
mannosidase, alpha, class 1A, member 2 |
chr8_-_110986918 | 1.10 |
ENST00000297404.1
|
KCNV1
|
potassium channel, subfamily V, member 1 |
chr1_+_248097071 | 1.08 |
ENST00000318244.3
|
OR2AJ1
|
olfactory receptor, family 2, subfamily AJ, member 1 |
chr11_-_63376013 | 1.07 |
ENST00000540943.1
|
PLA2G16
|
phospholipase A2, group XVI |
chr2_+_11696464 | 1.06 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr4_-_159956333 | 1.03 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
chr4_+_113568207 | 1.02 |
ENST00000511529.1
|
LARP7
|
La ribonucleoprotein domain family, member 7 |
chr3_-_107099454 | 1.00 |
ENST00000593837.1
ENST00000599431.1 |
RP11-446H18.5
|
RP11-446H18.5 |
chr3_+_145782358 | 0.99 |
ENST00000422482.1
|
AC107021.1
|
HCG1786590; PRO2533; Uncharacterized protein |
chr6_+_153552455 | 0.98 |
ENST00000392385.2
|
AL590867.1
|
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
chr8_+_92261516 | 0.96 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr6_-_87804815 | 0.95 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
chr3_+_35682913 | 0.93 |
ENST00000449196.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr7_+_99195677 | 0.92 |
ENST00000431679.1
|
GS1-259H13.2
|
GS1-259H13.2 |
chr12_-_86650154 | 0.91 |
ENST00000552435.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr2_-_183106641 | 0.91 |
ENST00000346717.4
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr5_-_173217916 | 0.91 |
ENST00000523617.1
|
CTB-43E15.4
|
CTB-43E15.4 |
chr5_-_173217931 | 0.90 |
ENST00000522731.1
|
CTB-43E15.4
|
CTB-43E15.4 |
chr3_-_196242233 | 0.89 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
chr2_-_178753465 | 0.88 |
ENST00000389683.3
|
PDE11A
|
phosphodiesterase 11A |
chr5_+_179135246 | 0.86 |
ENST00000508787.1
|
CANX
|
calnexin |
chr4_-_100575781 | 0.86 |
ENST00000511828.1
|
RP11-766F14.2
|
Protein LOC285556 |
chr6_+_161123270 | 0.86 |
ENST00000366924.2
ENST00000308192.9 ENST00000418964.1 |
PLG
|
plasminogen |
chr18_+_72201664 | 0.85 |
ENST00000358821.3
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family) |
chr12_-_86650045 | 0.85 |
ENST00000604798.1
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr6_+_140175987 | 0.84 |
ENST00000414038.1
ENST00000431609.1 |
RP5-899B16.1
|
RP5-899B16.1 |
chr1_+_234765057 | 0.83 |
ENST00000429269.1
|
LINC00184
|
long intergenic non-protein coding RNA 184 |
chr6_+_47749718 | 0.83 |
ENST00000489301.2
ENST00000371211.2 ENST00000393699.2 |
OPN5
|
opsin 5 |
chr7_+_54398390 | 0.82 |
ENST00000458615.1
ENST00000426205.1 |
RP11-436F9.1
|
RP11-436F9.1 |
chr2_+_211342432 | 0.81 |
ENST00000430249.2
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial |
chr10_+_96698406 | 0.80 |
ENST00000260682.6
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
chr15_+_48483736 | 0.79 |
ENST00000417307.2
ENST00000559641.1 |
CTXN2
SLC12A1
|
cortexin 2 solute carrier family 12 (sodium/potassium/chloride transporter), member 1 |
chr2_+_211342400 | 0.79 |
ENST00000417946.1
ENST00000518043.1 ENST00000523702.1 |
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial |
chr8_-_30670384 | 0.79 |
ENST00000221138.4
ENST00000518243.1 |
PPP2CB
|
protein phosphatase 2, catalytic subunit, beta isozyme |
chr6_-_136847099 | 0.78 |
ENST00000438100.2
|
MAP7
|
microtubule-associated protein 7 |
chr3_-_114790179 | 0.78 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr8_-_112039643 | 0.77 |
ENST00000524283.1
|
RP11-946L20.2
|
RP11-946L20.2 |
chr12_-_86650077 | 0.77 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr11_+_112047087 | 0.75 |
ENST00000526088.1
ENST00000532593.1 ENST00000531169.1 |
BCO2
|
beta-carotene oxygenase 2 |
chr14_-_36990061 | 0.75 |
ENST00000546983.1
|
NKX2-1
|
NK2 homeobox 1 |
chr2_+_170366203 | 0.75 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
chr6_-_136847610 | 0.74 |
ENST00000454590.1
ENST00000432797.2 |
MAP7
|
microtubule-associated protein 7 |
chr9_-_21305312 | 0.74 |
ENST00000259555.4
|
IFNA5
|
interferon, alpha 5 |
chr2_+_101591314 | 0.74 |
ENST00000450763.1
|
NPAS2
|
neuronal PAS domain protein 2 |
chr3_-_141719195 | 0.73 |
ENST00000397991.4
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr8_-_42358742 | 0.73 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chrX_+_9935392 | 0.73 |
ENST00000445307.2
|
AC002365.1
|
Homo sapiens uncharacterized LOC100288814 (LOC100288814), mRNA. |
chr20_-_7921090 | 0.73 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
chr11_-_35287243 | 0.73 |
ENST00000464522.2
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr4_-_40477766 | 0.73 |
ENST00000507180.1
|
RBM47
|
RNA binding motif protein 47 |
chr19_-_35417716 | 0.73 |
ENST00000604333.1
|
CTC-523E23.8
|
CTC-523E23.8 |
chr6_+_78400375 | 0.71 |
ENST00000602452.2
|
MEI4
|
meiosis-specific 4 homolog (S. cerevisiae) |
chr2_-_211342292 | 0.71 |
ENST00000448951.1
|
LANCL1
|
LanC lantibiotic synthetase component C-like 1 (bacterial) |
chr2_-_165424973 | 0.70 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr8_+_1993173 | 0.70 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr8_+_1993152 | 0.70 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
chr12_+_20963632 | 0.70 |
ENST00000540853.1
ENST00000261196.2 |
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr2_+_182850743 | 0.70 |
ENST00000409702.1
|
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
chr15_+_54901540 | 0.69 |
ENST00000539562.2
|
UNC13C
|
unc-13 homolog C (C. elegans) |
chr4_-_34271356 | 0.69 |
ENST00000514877.1
|
RP11-548L20.1
|
RP11-548L20.1 |
chrX_-_130423200 | 0.69 |
ENST00000361420.3
|
IGSF1
|
immunoglobulin superfamily, member 1 |
chr17_+_35851570 | 0.69 |
ENST00000394386.1
|
DUSP14
|
dual specificity phosphatase 14 |
chrX_-_142605301 | 0.68 |
ENST00000370503.2
|
SPANXN3
|
SPANX family, member N3 |
chr17_-_10450866 | 0.68 |
ENST00000578017.1
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr7_-_64023441 | 0.68 |
ENST00000309683.6
|
ZNF680
|
zinc finger protein 680 |
chr18_+_616672 | 0.67 |
ENST00000338387.7
|
CLUL1
|
clusterin-like 1 (retinal) |
chr1_+_197237352 | 0.67 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
chr1_-_190446759 | 0.66 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr10_-_128210005 | 0.66 |
ENST00000284694.7
ENST00000454341.1 ENST00000432642.1 ENST00000392694.1 |
C10orf90
|
chromosome 10 open reading frame 90 |
chr4_+_159131630 | 0.66 |
ENST00000504569.1
ENST00000509278.1 ENST00000514558.1 ENST00000503200.1 |
TMEM144
|
transmembrane protein 144 |
chr10_+_114043493 | 0.66 |
ENST00000369422.3
|
TECTB
|
tectorin beta |
chrM_-_14670 | 0.66 |
ENST00000361681.2
|
MT-ND6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr4_+_69962185 | 0.65 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr7_-_107883678 | 0.64 |
ENST00000417701.1
|
NRCAM
|
neuronal cell adhesion molecule |
chr6_+_53883708 | 0.64 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
chr15_+_69857515 | 0.64 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chr8_+_42396274 | 0.62 |
ENST00000438528.3
|
SMIM19
|
small integral membrane protein 19 |
chr2_-_179672142 | 0.61 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
chr9_-_21351377 | 0.61 |
ENST00000380210.1
|
IFNA6
|
interferon, alpha 6 |
chr5_-_74162739 | 0.61 |
ENST00000513277.1
|
FAM169A
|
family with sequence similarity 169, member A |
chr13_+_24144796 | 0.61 |
ENST00000403372.2
|
TNFRSF19
|
tumor necrosis factor receptor superfamily, member 19 |
chr14_-_80697396 | 0.61 |
ENST00000557010.1
|
DIO2
|
deiodinase, iodothyronine, type II |
chr2_+_234580525 | 0.60 |
ENST00000609637.1
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chrX_-_9734004 | 0.60 |
ENST00000467482.1
ENST00000380929.2 |
GPR143
|
G protein-coupled receptor 143 |
chr6_+_134758827 | 0.59 |
ENST00000431422.1
|
LINC01010
|
long intergenic non-protein coding RNA 1010 |
chr1_+_196912902 | 0.58 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
chr4_+_69962212 | 0.58 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr16_-_66584059 | 0.57 |
ENST00000417693.3
ENST00000544898.1 ENST00000569718.1 ENST00000527284.1 ENST00000299697.7 ENST00000451102.2 |
TK2
|
thymidine kinase 2, mitochondrial |
chrX_+_36246735 | 0.57 |
ENST00000378653.3
|
CXorf30
|
chromosome X open reading frame 30 |
chr4_-_122854612 | 0.57 |
ENST00000264811.5
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr4_-_177190364 | 0.57 |
ENST00000296525.3
|
ASB5
|
ankyrin repeat and SOCS box containing 5 |
chr4_+_69681710 | 0.56 |
ENST00000265403.7
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr12_+_58176525 | 0.56 |
ENST00000543727.1
ENST00000540550.1 ENST00000323833.8 ENST00000350762.5 ENST00000550559.1 ENST00000548851.1 ENST00000434359.1 ENST00000457189.1 |
TSFM
|
Ts translation elongation factor, mitochondrial |
chr17_+_61473104 | 0.55 |
ENST00000583016.1
|
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr2_+_87135076 | 0.55 |
ENST00000409776.2
|
RGPD1
|
RANBP2-like and GRIP domain containing 1 |
chr4_+_48807155 | 0.55 |
ENST00000504654.1
|
OCIAD1
|
OCIA domain containing 1 |
chr18_+_47087055 | 0.55 |
ENST00000577628.1
|
LIPG
|
lipase, endothelial |
chr3_-_141747950 | 0.55 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr16_-_66583994 | 0.55 |
ENST00000564917.1
|
TK2
|
thymidine kinase 2, mitochondrial |
chr5_-_88120151 | 0.55 |
ENST00000506716.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr5_+_140201183 | 0.54 |
ENST00000529619.1
ENST00000529859.1 ENST00000378126.3 |
PCDHA5
|
protocadherin alpha 5 |
chr9_+_12695702 | 0.54 |
ENST00000381136.2
|
TYRP1
|
tyrosinase-related protein 1 |
chr12_+_20963647 | 0.54 |
ENST00000381545.3
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3 |
chr17_-_10372875 | 0.54 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
chr5_-_135290651 | 0.53 |
ENST00000522943.1
ENST00000514447.2 |
LECT2
|
leukocyte cell-derived chemotaxin 2 |
chr6_-_52859968 | 0.53 |
ENST00000370959.1
|
GSTA4
|
glutathione S-transferase alpha 4 |
chr2_-_166930131 | 0.53 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr4_-_9390709 | 0.53 |
ENST00000508324.1
|
RP11-1396O13.13
|
Uncharacterized protein |
chr1_-_182921119 | 0.52 |
ENST00000423786.1
|
SHCBP1L
|
SHC SH2-domain binding protein 1-like |
chr1_-_204183071 | 0.52 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
chr1_+_215179188 | 0.52 |
ENST00000391895.2
|
KCNK2
|
potassium channel, subfamily K, member 2 |
chr7_-_35013217 | 0.52 |
ENST00000446375.1
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
chr16_-_52061283 | 0.52 |
ENST00000566314.1
|
C16orf97
|
chromosome 16 open reading frame 97 |
chr9_-_85882145 | 0.52 |
ENST00000328788.1
|
FRMD3
|
FERM domain containing 3 |
chr12_-_39734783 | 0.52 |
ENST00000552961.1
|
KIF21A
|
kinesin family member 21A |
chr4_+_95128748 | 0.51 |
ENST00000359052.4
|
SMARCAD1
|
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 |
chr14_+_37641012 | 0.51 |
ENST00000556667.1
|
SLC25A21-AS1
|
SLC25A21 antisense RNA 1 |
chr11_+_22696314 | 0.51 |
ENST00000532398.1
ENST00000433790.1 |
GAS2
|
growth arrest-specific 2 |
chr8_-_62559366 | 0.51 |
ENST00000522919.1
|
ASPH
|
aspartate beta-hydroxylase |
chr2_+_234580499 | 0.51 |
ENST00000354728.4
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr4_+_155484103 | 0.51 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr14_-_67878917 | 0.51 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
chr5_-_117897751 | 0.51 |
ENST00000515704.1
ENST00000506769.1 |
CTD-2281M20.1
|
CTD-2281M20.1 |
chrX_-_9734038 | 0.51 |
ENST00000431126.1
|
GPR143
|
G protein-coupled receptor 143 |
chr5_+_67588312 | 0.50 |
ENST00000519025.1
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr8_-_133637624 | 0.50 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
chr4_+_41540160 | 0.50 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr5_+_147648393 | 0.50 |
ENST00000511106.1
ENST00000398450.4 |
SPINK13
|
serine peptidase inhibitor, Kazal type 13 (putative) |
chr5_+_81575281 | 0.50 |
ENST00000380167.4
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
chr16_+_53412368 | 0.49 |
ENST00000565189.1
|
RP11-44F14.2
|
RP11-44F14.2 |
chr14_-_47351391 | 0.49 |
ENST00000399222.3
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2 |
chr19_+_42349092 | 0.49 |
ENST00000269945.3
ENST00000596258.1 |
DMRTC2
|
DMRT-like family C2 |
chr5_-_36301984 | 0.49 |
ENST00000502994.1
ENST00000515759.1 ENST00000296604.3 |
RANBP3L
|
RAN binding protein 3-like |
chr11_-_5323226 | 0.49 |
ENST00000380224.1
|
OR51B4
|
olfactory receptor, family 51, subfamily B, member 4 |
chr18_-_59274139 | 0.49 |
ENST00000586949.1
|
RP11-879F14.2
|
RP11-879F14.2 |
chr9_+_67977438 | 0.48 |
ENST00000456982.1
|
RP11-195B21.3
|
Protein LOC644249 |
chr6_-_138833630 | 0.47 |
ENST00000533765.1
|
NHSL1
|
NHS-like 1 |
chr5_+_36608280 | 0.47 |
ENST00000513646.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr4_-_118006697 | 0.47 |
ENST00000310754.4
|
TRAM1L1
|
translocation associated membrane protein 1-like 1 |
chr6_+_26104104 | 0.47 |
ENST00000377803.2
|
HIST1H4C
|
histone cluster 1, H4c |
chr16_-_3350614 | 0.46 |
ENST00000268674.2
|
TIGD7
|
tigger transposable element derived 7 |
chr8_-_42396185 | 0.46 |
ENST00000518717.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr9_-_23779367 | 0.46 |
ENST00000440102.1
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr19_-_36001113 | 0.46 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr4_+_155484155 | 0.46 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr6_-_24358264 | 0.46 |
ENST00000378454.3
|
DCDC2
|
doublecortin domain containing 2 |
chr13_+_78315348 | 0.46 |
ENST00000441784.1
|
SLAIN1
|
SLAIN motif family, member 1 |
chr2_+_191221240 | 0.46 |
ENST00000409027.1
ENST00000458193.1 |
INPP1
|
inositol polyphosphate-1-phosphatase |
chr11_+_120973375 | 0.46 |
ENST00000264037.2
|
TECTA
|
tectorin alpha |
chr5_+_43602750 | 0.45 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
chr5_-_175388327 | 0.45 |
ENST00000432305.2
ENST00000505969.1 |
THOC3
|
THO complex 3 |
chr3_+_138340067 | 0.45 |
ENST00000479848.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
chr15_+_65843130 | 0.45 |
ENST00000569894.1
|
PTPLAD1
|
protein tyrosine phosphatase-like A domain containing 1 |
chr9_-_93405352 | 0.45 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr12_-_67197760 | 0.45 |
ENST00000539540.1
ENST00000540433.1 ENST00000541947.1 ENST00000538373.1 |
GRIP1
|
glutamate receptor interacting protein 1 |
chrX_+_83116142 | 0.45 |
ENST00000329312.4
|
CYLC1
|
cylicin, basic protein of sperm head cytoskeleton 1 |
chr6_+_26087509 | 0.45 |
ENST00000397022.3
ENST00000353147.5 ENST00000352392.4 ENST00000349999.4 ENST00000317896.7 ENST00000357618.5 ENST00000470149.1 ENST00000336625.8 ENST00000461397.1 ENST00000488199.1 |
HFE
|
hemochromatosis |
chr14_+_24540046 | 0.45 |
ENST00000397016.2
ENST00000537691.1 ENST00000560356.1 ENST00000558450.1 |
CPNE6
|
copine VI (neuronal) |
chrX_-_52827141 | 0.44 |
ENST00000375511.3
|
SPANXN5
|
SPANX family, member N5 |
chr6_+_29429217 | 0.44 |
ENST00000396792.2
|
OR2H1
|
olfactory receptor, family 2, subfamily H, member 1 |
chr18_+_47087390 | 0.44 |
ENST00000583083.1
|
LIPG
|
lipase, endothelial |
chr2_+_120687335 | 0.44 |
ENST00000544261.1
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chrX_+_36254051 | 0.44 |
ENST00000378657.4
|
CXorf30
|
chromosome X open reading frame 30 |
chr15_+_50474385 | 0.44 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr5_+_125798031 | 0.44 |
ENST00000502348.1
|
GRAMD3
|
GRAM domain containing 3 |
chr4_-_122302163 | 0.43 |
ENST00000394427.2
|
QRFPR
|
pyroglutamylated RFamide peptide receptor |
chr10_+_127585093 | 0.43 |
ENST00000368695.1
ENST00000368693.1 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
chr3_+_28390637 | 0.43 |
ENST00000420223.1
ENST00000383768.2 |
ZCWPW2
|
zinc finger, CW type with PWWP domain 2 |
chr18_+_5748793 | 0.43 |
ENST00000566533.1
ENST00000562452.2 |
RP11-945C19.1
|
RP11-945C19.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.6 | 1.8 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.5 | 1.6 | GO:0070408 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.4 | 2.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 1.1 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.3 | 1.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.3 | 1.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.3 | 1.1 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.3 | 0.8 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.2 | 1.0 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.2 | 1.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.7 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
0.2 | 0.7 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.2 | 4.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 1.1 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 2.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.5 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.2 | 1.8 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.2 | 1.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.7 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.5 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.5 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.8 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.3 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 1.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.3 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.1 | 0.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 2.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 1.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 1.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:2000395 | positive regulation of viral budding via host ESCRT complex(GO:1903774) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.3 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.5 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 0.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 2.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.4 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.1 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.3 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 2.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 1.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.3 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.0 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 5.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.7 | GO:0043069 | negative regulation of apoptotic process(GO:0043066) negative regulation of programmed cell death(GO:0043069) |
0.0 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.0 | 0.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.7 | GO:2000291 | regulation of pseudopodium assembly(GO:0031272) regulation of myoblast proliferation(GO:2000291) |
0.0 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.4 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.9 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.3 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 1.4 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.0 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.9 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.4 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.0 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.6 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.5 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.0 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.4 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.0 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.0 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 1.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.6 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.3 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 1.2 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 1.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.0 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.0 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.5 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 0.0 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 5.1 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 2.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.9 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.9 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 1.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 4.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.0 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 5.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 2.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 1.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 2.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.8 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.7 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 1.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.0 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.6 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.4 | 1.1 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.3 | 0.9 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.3 | 2.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.2 | 0.7 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.2 | 1.4 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.2 | 1.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 2.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 7.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.8 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.2 | 0.7 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.2 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 2.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.8 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 2.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.5 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.4 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.1 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.7 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.1 | 0.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 2.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.4 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.1 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.4 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.1 | 0.9 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 3.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.5 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 2.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 3.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 1.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.0 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.3 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 2.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 1.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.7 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.0 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 1.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 2.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 2.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 4.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 3.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 1.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 2.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 5.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 5.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 4.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |